Yoshino Y, Yamanaka Y, Oda A
Am J Case Rep. 2024; 25():e945301.
PMID: 39344100
PMC: 11452142.
DOI: 10.12659/AJCR.945301.
Kumar I, Ansari M, Verma A, Singh P, Chakrabarti S, Shukla R
Indian J Radiol Imaging. 2024; 34(4):714-725.
PMID: 39318578
PMC: 11419762.
DOI: 10.1055/s-0044-1785210.
Nune A, Durkowski V, Pillay S, Barman B, Elwell H, Bora K
Vaccines (Basel). 2023; 11(10).
PMID: 37896974
PMC: 10610967.
DOI: 10.3390/vaccines11101571.
Ebrahimi R, Mounesi Sohi A, Khonji M, Ghafouri K
Radiol Case Rep. 2023; 18(12):4309-4312.
PMID: 37800119
PMC: 10550500.
DOI: 10.1016/j.radcr.2023.08.056.
Ryad R, Osman A, Almusa A, Gerges P, Sumbul-Yuksel B
Cureus. 2023; 15(8):e44324.
PMID: 37779754
PMC: 10538353.
DOI: 10.7759/cureus.44324.
Myositis unrelated to the inoculation site after COVID-19 vaccination: a case report.
Han J, Oh J, Lee D, Jeon Y
Clin Shoulder Elb. 2023; 26(2):208-211.
PMID: 37088882
PMC: 10277710.
DOI: 10.5397/cise.2022.00983.
COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report.
Syrmou V, Liaskos C, Ntavari N, Mitsimponas K, Simopoulou T, Alexiou I
Immunol Res. 2023; 71(4):537-546.
PMID: 36928720
PMC: 10018601.
DOI: 10.1007/s12026-023-09368-2.
Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-Series.
Liozon E, Filloux M, Parreau S, Gondran G, Bezanahary H, Ly K
J Clin Med. 2022; 11(24).
PMID: 36556100
PMC: 9785620.
DOI: 10.3390/jcm11247484.
Kidney injury associated with COVID-19 infection and vaccine: A narrative review.
Pacheco I, Costa D, Sousa D, Filho N, Silva G, de Menezes Neves P
Front Med (Lausanne). 2022; 9:956158.
PMID: 36544502
PMC: 9760714.
DOI: 10.3389/fmed.2022.956158.
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review.
Ding Y, Ge Y
Front Public Health. 2022; 10:1007637.
PMID: 36339243
PMC: 9634642.
DOI: 10.3389/fpubh.2022.1007637.
Skeletal Muscle Disease: Imaging Findings Simplified.
Theodorou D, Theodorou S, Saba L, Kakitsubata Y
Cureus. 2022; 14(9):e29655.
PMID: 36320982
PMC: 9612277.
DOI: 10.7759/cureus.29655.
Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report.
Li J, Siglin J, Marshall M, Stemmer-Rachamimov A, Bloom S, Blumenthal K
Open Forum Infect Dis. 2022; 9(10):ofac499.
PMID: 36267257
PMC: 9578160.
DOI: 10.1093/ofid/ofac499.
Bilateral upper extremity myositis after COVID-19 vaccination.
Godoy I, Cantarelli Rodrigues T, Skaf A
BJR Case Rep. 2022; 8(5):20220002.
PMID: 36211612
PMC: 9518739.
DOI: 10.1259/bjrcr.20220002.
Immunogenicity and safety of two-dose SARS-CoV-2 vaccination different platforms in kidney transplantation recipients.
Chen C, Huang Y, Lai M, Lin M, Lin W, Lin H
Front Immunol. 2022; 13:951576.
PMID: 36189313
PMC: 9523367.
DOI: 10.3389/fimmu.2022.951576.
COVID-19 vaccine-associated myositis - a case report.
Bose P, Goenka U, Moitra S, Majumdar S, Goenka M, Sen S
Clin Case Rep. 2022; 10(9):e6314.
PMID: 36110335
PMC: 9465691.
DOI: 10.1002/ccr3.6314.
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
Rodriguez Y, Rojas M, Beltran S, Polo F, Camacho-Dominguez L, Morales S
J Autoimmun. 2022; 132:102898.
PMID: 36041291
PMC: 9399140.
DOI: 10.1016/j.jaut.2022.102898.
Isolated Infraspinatus Myositis after Intramuscular Vaccine Administration.
Samuelson E, Bano J, Gould H, Levine R
Case Rep Orthop. 2022; 2022:1363462.
PMID: 36034749
PMC: 9410995.
DOI: 10.1155/2022/1363462.
Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis.
Magen E, Mukherjee S, Bhattacharya M, Detroja R, Merzon E, Blum I
Vaccines (Basel). 2022; 10(7).
PMID: 35891299
PMC: 9324661.
DOI: 10.3390/vaccines10071135.
Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.
Jacob S, Kapadia R, Soule T, Luo H, Schellenberg K, Douville R
Front Neurol. 2022; 13:914411.
PMID: 35812094
PMC: 9263266.
DOI: 10.3389/fneur.2022.914411.
Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies.
Garcia-Bravo L, Calle-Rubio M, Fernandez-Arquero M, Mohamed Mohamed K, Guerra-Galan T, Guzman-Fulgencio M
J Transl Autoimmun. 2022; 5:100160.
PMID: 35789569
PMC: 9242685.
DOI: 10.1016/j.jtauto.2022.100160.
